CCL2 and congenital diaphragmatic hernia: In the present study, we show for the first time that prenatal application of rosiglitazone on D18 and D19 reduced MCP-1 expression, monocyte/macrophage infiltration and vascular remodeling in fetuses with CDH compared to placebo-treated animals.